HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of HealthEquity (NASDAQ:HQY) from a hold rating to a buy rating in a report issued on Saturday.

A number of other equities analysts also recently issued reports on the company. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Royal Bank Of Canada raised their target price on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday, June 1st. Eleven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Stock Performance

HQY opened at $105.40 on Friday. HealthEquity has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a market cap of $8.81 billion, a price-to-earnings ratio of 39.48, a PEG ratio of 1.77 and a beta of 0.21. The company’s fifty day moving average price is $97.01 and its two-hundred day moving average price is $87.37. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts expect that HealthEquity will post 3.92 EPS for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares of the company’s stock, valued at $4,963,180. This trade represents a 4.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is owned by company insiders.

Institutional Trading of HealthEquity

Hedge funds have recently added to or reduced their stakes in the stock. Acumen Wealth Advisors LLC bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $28,000. Leonteq Securities AG lifted its stake in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after purchasing an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC purchased a new position in HealthEquity in the first quarter valued at approximately $33,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.